Capital Flow Monitor · Sponsors · CIK 1716636
Alpheus Medical, Inc.
1266 Park Road, Chanhassen, MN, 55317 · 310-413-4338
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$67.0M
Sold
$60.5M
% sold
90.3%
Investors
22
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-30 | D/A ·current | 506(b) | $67.0M | $60.5M | 90.3% | 22 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Vijay Agarwal — Executive Officer / Director, Chanhassen, MN
- Jeremy Ling — Executive Officer, Chanhassen, MN
- Imran Eba — Executive Officer, Chanhassen, MN
-
John Johnson — Director, Chanhassen, MN
4 other raises
- Imitation Development Ltd Liability Co $0 of $5.0M · 0.0%
- Show Biz, Its Just Show Biz Ltd Liability Co $520K of $4.0M · 13.0%
- Face Split Open Ltd Liability Co $125K of $1.8M · 6.9%
- Little Nuance Ltd Liability Co $0 of $1.3M · 0.0%
- Robert Stein — Director, Chanhassen, MN
-
Juan-Pablo Mas — Director, Chanhassen, MN
2 other raises
- Saluda Medical, Inc. $30.0M of $30.0M · 100.0%
- SetPoint Medical Corp $115.5M of $115.5M · 100.0%
-
Peter Thompson — Director, Chanhassen, MN
2 other raises
- Terremoto Biosciences, Inc. $40.7M of $108.6M · 37.5%
- Sparrow Pharmaceuticals, Inc. $61.8M of $121.4M · 50.9%
-
Klaus Veitinger — Director, Chanhassen, MN
1 other raise
- Sparrow Pharmaceuticals, Inc. $61.8M of $121.4M · 50.9%
- Steve Weiner — Executive Officer, Chanhassen, MN
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.